Situation
- UK Affiliate of global pharma
- Build robust UK reputation following profile spike
- Aiming to build reputation and drive differentiation from other big pharma in the UK
- Secure stakeholder support to drive commercial objectives
Actions
- Assess impact of current approach
- Engage and align cross-functional UK leadership/external facing team in a strategic approach to stakeholder relations
- Rigorous stakeholder analysis and prioritisation
- Build longer term approach around external influencers
- Align and integrate with Global functions, corporate affairs, and R&D
- Commit to consistent and relevant messaging and materials
Results
- Practical basis for building an aligned, sustainable reputation
- Leadership commitment
- Global support and buy-in